다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Journal of hepatology : the journal of the European Association for the Study of the Liver, v.27 no.2, 1997년, pp.259 - 264
Hohler, T. (bInstitute for Legal Medicine, Johannes Gutenberg University Mainz,, , Germany) , Gerken, G. , Notghi, A. , Knolle, P. , Lubjuhn, R. , Taheri, H. , Schneider, P.M. , zum Buschenfelde, K.-H.M. , Rittner, C.
AI-Helper
Background/Aims: Chronic hepatitis C develops in more than 70% of hepatitis C virus infected subjects. Viral factors influence the disease course, but little is known about the importance of host factors.Methods: Frequencies of major histocompatibility complex (MHC) class I and class I antigens were...
N Engl J Med Terrault 332 1509 1995 10.1056/NEJM199506013322211 Interferon and hepatitis C
N Engl J Med Tong 332 1463 1995 10.1056/NEJM199506013322202 Clinical outcomes after transfusion-associated hepatitis C
N Engl J Med Alter 327 1899 1992 10.1056/NEJM199212313272702 The natural history of community-acquired hepatitis C in the United States
N Engl J Med Alter 321 1494 1989 10.1056/NEJM198911303212202 Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis
Hepatology Yoshioka 16 293 1992 10.1002/hep.1840160203 Detection of hepatitis C virus by polymerase chain reaction and respone to interferon-alpha therapy: relationship to genotypes of hepatitis C virus
Hepatology Dusheiko 19 13 1994 10.1002/hep.1840190104 Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease
Lancet Diepolder 346 1006 1995 10.1016/S0140-6736(95)91691-1 Possible mechanisms involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection
J Hepatol Gonzalez-Peralta 21 255 1994 10.1016/S0168-8278(05)80405-2 Pathogenetic mechanisms of hepatocellular damage in chronic hepatitis C virus infection
J Immunol Koziel 149 3339 1992 10.4049/jimmunol.149.10.3339 Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis
J Clin Invest Ballardini 95 2067 1995 10.1172/JCI117893
Nature Genet Apple 6 157 1994 10.1038/ng0294-157 HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity
N Engl J Med Thursz 332 1065 1995 10.1056/NEJM199504203321604 Association between an MHC class II allele and clearance of the hepatitis B virus in Gambia
Arch Intern Med Peano 154 2733 1994 10.1001/archinte.1994.00420230126015 HLA-DR5 antigen. A genetic factor influencing the outcome of hepatitis C virus infection?
Hepatology Czaja 18 816 1993 10.1002/hep.1840180411 Genetic predisposition for the immunological features of chronic active hepatitis
Gastroenterology Czaja 108 157 1995 10.1016/0016-5085(95)90020-9 Immunologic features and HLA associations in chronic viral hepatitis
J Hepatol Höhler 26 503 1997 10.1016/S0168-8278(97)80414-X HLA-DRB1*1301 and *1302 protect against chronic hepatitis B
Lancet Manns ii 292 1987 10.1016/S0140-6736(87)92024-1 Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against soluble liver antigen
Am J Clin Pathol Terasaki 69 103 1978 10.1093/ajcp/69.2.103 Microdroplet testing for HLA-A, - B, -C and -D antigens
Tissue Antigens Bein 39 68 1992 10.1111/j.1399-0039.1992.tb01909.x Rapid HLA-DRB1 genotyping by nested PCR amplification
Kimura 397 1991 Eleventh International Histocompatibility Workshop reference protocol for the HLA DNA-typing technique
J Gen Virol Stuyver 74 1105 1993 10.1099/0022-1317-74-6-1093 Typing of hepatitis C virus isolate and characterisation of new subtypes using a line probe assay
Svejgaard 1986 HLA and disease
Biometrics Guo 48 361 1992 10.2307/2532296 Performing the exact test of Hardy-Weinberg proportion for multiple alleles
J Immunol Begovich 148 249 1992 10.4049/jimmunol.148.1.249 Polymorphism, recombination, and linkage disequilibrium within the HLA class II region
Gastro-enterology Lunel 107 1550 1994 10.1016/0016-5085(94)90564-9 Hepatitis C virus and autoimmunity: fortuitous association or reality?
J Hepatol Meyer zum Büschenfelde 22 93 1995 The role of autoimmunity in hepatitis C infection
Hepatology Donaldson 13 701 1991 10.1002/hep.1840130415 Susceptibility of autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors
Hepatology Mayet 10 24 1989 10.1002/hep.1840100106 Treatment of chronic type B hepatitis with recombinant α-interferon induces autoantibodies not specific for autoimmune chronic hepatitis
Gastroenterology García-Buey 108 1770 1995 10.1016/0016-5085(95)90139-6 Latent autoimmune hepatitis triggered during interferon therapy in patients with chronic hepatitis C
Tissue Antigens Vitte 45 356 1995 10.1111/j.1399-0039.1995.tb02467.x HLA antigens in patients with chronic hepatitis C
J Hepatol Czaja 24 666 1996 10.1016/S0168-8278(96)80261-3 DR leukocyte antigens and disease severity in chronic hepatitis C
J Med Virol Kuzushita 48 1 1996 10.1002/(SICI)1096-9071(199601)48:1<1::AID-JMV1>3.0.CO;2-E Increased frequency of HLA DR13 in hepatitis C virus carriers with persistently normal ALT levels
Nature Hill 352 595 1991 10.1038/352595a0 Common West African HLA antigens are associated with protection from severe malaria
Immunogenetics Rammensee 41 178 1995 10.1007/BF00172063 MHC ligands and peptide motifs: first listing
Hepatology Ferrari 19 286 1994 10.1002/hep.1840190205 T-cell response to structural and non-structural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections
해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.